Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| SEZL | Paradis Paul | Director & President | 08/10/2026 | Steuer-Abgabe | 118.00 | 7,110 | 838,980 | Form 4 |
| SEZL | Krause Justin | SVP FINANCE AND CONTROLLER | 08/10/2026 | Steuer-Abgabe | 118.00 | 1,571 | 185,378 | Form 4 |
| SEZL | Sabzivand Amin | Chief Operating Officer | 08/10/2026 | Steuer-Abgabe | 118.00 | 6,973 | 822,814 | Form 4 |
| SEZL | Brading Lee Dickson | Chief Financial Officer | 08/10/2026 | Steuer-Abgabe | 118.00 | 1,405 | 165,790 | Form 4 |
| SENEA | Palmby Paul Laurence | President & CEO | 08/05/2026 | Zuteilung | — | 2,500 | — | Form 4 |
| SENEA | Wolcott Michael S | SVP, CFO & Treasurer | 08/05/2026 | Zuteilung | — | 1,000 | — | Form 4 |
| SENEA | Nelson Timothy Robert | Chief Operating Officer | 08/05/2026 | Zuteilung | — | 1,000 | — | Form 4 |
| SENEA | Erstad Dean Everett | Senior VP Sales & Marketing | 08/05/2026 | Zuteilung | — | 1,000 | — | Form 4 |
| SENEA | Ide Gregory R | VP, Controller/Asst.Secretary | 08/05/2026 | Zuteilung | — | 500 | — | Form 4 |
| SEIC | McCabe Philip | See Remarks | 08/05/2026 | Verkauf | 105.50 | 5,043 | 532,037 | Form 4 |
| SEIC | McCabe Philip | See Remarks | 08/05/2026 | Optionsausübung | 49.63 | 5,043 | 250,284 | Form 4 |
| SEIC | McCabe Philip | See Remarks | 08/04/2026 | Verkauf | 105.04 | 24,957 | 2,621,433 | Form 4 |
| SEIC | McCabe Philip | See Remarks | 08/04/2026 | Optionsausübung | 49.63 | 15,000 | 744,450 | Form 4 |
| SEIC | McCabe Philip | See Remarks | 08/04/2026 | Optionsausübung | 49.63 | 9,957 | 494,166 | Form 4 |
| SEPN | Long Daniel D. | SVP, Drug Discovery | 08/03/2026 | Verkauf | 34.68 | 2,334 | 80,944 | Form 4 |
| SEPN | Long Daniel D. | SVP, Drug Discovery | 08/03/2026 | Verkauf | 33.98 | 1,000 | 33,976 | Form 4 |
| SEPN | Long Daniel D. | SVP, Drug Discovery | 08/03/2026 | Optionsausübung | 2.76 | 1,518 | 4,190 | Form 4 |
| SEPN | Long Daniel D. | SVP, Drug Discovery | 08/03/2026 | Optionsausübung | 2.76 | 1,816 | 5,012 | Form 4 |
| SEIC | Mccarthy Kathryn | Director | 08/03/2026 | Verkauf | 103.54 | 10,000 | 1,035,350 | Form 4 |
| SEIC | Mccarthy Kathryn | Director | 08/03/2026 | Optionsausübung | 71.12 | 5,000 | 355,600 | Form 4 |
| SEG | Sachs Rebecca E. | Chief Administrative Officer | 07/31/2026 | Steuer-Abgabe | 26.23 | 1,010 | 26,492 | Form 4 |
| SEG | Elaiwat Lenah | Chief Financial Officer | 07/31/2026 | Steuer-Abgabe | 26.23 | 741 | 19,436 | Form 4 |
| SEG | Partridge Matthew Morris | Chief Executive Officer | 07/31/2026 | Steuer-Abgabe | 26.23 | 4,544 | 119,189 | Form 4 |
| SEER | Gulyani Meeta | Director | 07/28/2026 | Zuteilung | — | 16,500 | — | Form 4 |
| SEER | Ro Isaac | Director | 07/28/2026 | Zuteilung | — | 12,375 | — | Form 4 |
| SEER | Nishar Dipchand | Director | 07/28/2026 | Zuteilung | — | 16,500 | — | Form 4 |
| SEER | Roelofs Nicolas H PHD | Director | 07/28/2026 | Zuteilung | — | 16,500 | — | Form 4 |
| SEER | Langer Robert | Director | 07/28/2026 | Zuteilung | — | 16,500 | — | Form 4 |
| SEER | Mcguire Terrance | Director | 07/28/2026 | Zuteilung | — | 16,500 | — | Form 4 |
| SEIC | Warner Mark Andrew | See Remarks* | 07/28/2026 | Verkauf | 102.97 | 7,400 | 761,993 | Form 4 |
| SEIC | Warner Mark Andrew | See Remarks* | 07/28/2026 | Verkauf | 102.01 | 5,300 | 540,658 | Form 4 |
| SEIC | Warner Mark Andrew | See Remarks* | 07/28/2026 | Verkauf | 101.11 | 2,300 | 232,542 | Form 4 |
| SEIC | Warner Mark Andrew | See Remarks* | 07/28/2026 | Optionsausübung | 56.54 | 5,000 | 282,700 | Form 4 |
| SEIC | Warner Mark Andrew | See Remarks* | 07/28/2026 | Optionsausübung | 64.43 | 2,500 | 161,075 | Form 4 |
| SEIC | Peterson Michael | Executive Vice President | 07/28/2026 | Verkauf | 102.05 | 25,000 | 2,551,250 | Form 4 |
| SEIC | Peterson Michael | Executive Vice President | 07/28/2026 | Optionsausübung | 55.73 | 25,000 | 1,393,250 | Form 4 |
| SEIC | Guarino Carl | Director | 07/28/2026 | Verkauf | 103.20 | 10,000 | 1,031,950 | Form 4 |
| SEIC | Guarino Carl | Director | 07/28/2026 | Optionsausübung | 49.63 | 5,000 | 248,150 | Form 4 |
| SEIC | Sharma Sanjay | See Remarks* | 07/24/2026 | Verkauf | 99.33 | 20,000 | 1,986,588 | Form 4 |
| SEIC | Sharma Sanjay | See Remarks* | 07/24/2026 | Optionsausübung | 71.12 | 10,000 | 711,200 | Form 4 |
| SEIC | Shah Sneha S. | See Remarks* | 07/24/2026 | Steuer-Abgabe | 96.73 | 3,746 | 362,351 | Form 4 |
| SEZL | Paradis Paul | Director & President | 07/16/2026 | Verkauf | 194.52 | 400 | 77,806 | Form 4 |
| SEZL | Paradis Paul | Director & President | 07/16/2026 | Verkauf | 193.52 | 1,700 | 328,983 | Form 4 |
| SEZL | Paradis Paul | Director & President | 07/16/2026 | Verkauf | 192.19 | 500 | 96,093 | Form 4 |
| SEZL | Paradis Paul | Director & President | 07/16/2026 | Verkauf | 191.21 | 900 | 172,085 | Form 4 |
| SEZL | Paradis Paul | Director & President | 07/16/2026 | Verkauf | 190.25 | 7,232 | 1,375,879 | Form 4 |
| SEZL | Brading Lee Dickson | Chief Financial Officer | 07/16/2026 | Verkauf | 195.03 | 434 | 84,642 | Form 4 |
| SEZL | Paradis Paul | Director & President | 07/15/2026 | Verkauf | 192.89 | 600 | 115,731 | Form 4 |
| SEZL | Paradis Paul | Director & President | 07/15/2026 | Verkauf | 191.86 | 2,362 | 453,162 | Form 4 |
| SEZL | Paradis Paul | Director & President | 07/15/2026 | Verkauf | 190.39 | 5,283 | 1,005,821 | Form 4 |
| SEZL | Brading Lee Dickson | Chief Financial Officer | 07/15/2026 | Verkauf | 190.30 | 5,000 | 951,506 | Form 4 |
| SEZL | Brading Lee Dickson | Chief Financial Officer | 07/15/2026 | Verkauf | 188.08 | 270 | 50,782 | Form 4 |
| SEZL | Brading Lee Dickson | Chief Financial Officer | 07/15/2026 | Verkauf | 187.45 | 1,200 | 224,940 | Form 4 |
| SEZL | Brading Lee Dickson | Chief Financial Officer | 07/15/2026 | Verkauf | 186.45 | 1,104 | 205,841 | Form 4 |
| SEZL | Brading Lee Dickson | Chief Financial Officer | 07/15/2026 | Verkauf | 185.38 | 2,326 | 431,199 | Form 4 |
| SEPN | Bhatt Elizabeth | President and COO | 07/15/2026 | Verkauf | 33.99 | 4,000 | 135,974 | Form 4 |
| SEPN | Bhatt Elizabeth | President and COO | 07/15/2026 | Optionsausübung | 6.81 | 4,000 | 27,240 | Form 4 |
| SERA | Phillips Joshua | Director | 07/10/2026 | Zuteilung | — | 2,260 | — | Form 4 |
| SERA | Phillips Joshua | Director | 07/10/2026 | Zuteilung | — | 22,426 | — | Form 4 |
| SERA | Barlow Jane F | Director | 07/10/2026 | Zuteilung | — | 1,949 | — | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).